-->
About
Who We Are
Management Team
Board of Directors
Scientific Advisors
Research
Pipeline Overview
Plinabulin
Other Pipeline
Protein Degradation
Posters & Publications
Collaboration
Expanded Access Policy
News & Media
Press Releases
Media Coverage
Investors
Stock Information
Events & Presentations
Financials & Filings
Corporate Governance
Contact Us
Media Coverage
Press Releases
Media Coverage
Media Coverage
December 10, 2020
New Treatment Modalities: Protein Degraders And Molecular Glues Gain Traction
Detail
November 13, 2020
Seed Therapeutics blossoms in an $800M deal with Lilly
Detail
October 14, 2020
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
Detail
October 12, 2020
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
Detail
September 29, 2020
JAMA Oncology Highlights Plinabulin's Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
Detail
January 31, 2020
Pegfilgrastim Plus Plinabulin Reduces Chemo-Induced Neutropenia in TAC-Treated Patients
Detail
October 29, 2019
Dr. Lan Huang Featured in Nature Titled "'Innovation' Nation"
Detail
August 21, 2019
Woman of the Week Podcast: Dr. Lan Huang, Co-founder, Chairman and Chief Executive Officer, BeyondSpring
Detail
July 30, 2019
Developing Triple-Combination Immunotherapies: Lessons Learned From HIV
Detail
目前在第
1
页,
共有
2
页,
共有
12
条记录
第一页
上一页
1
2
下一页
最后一页
跳转到
页
Terms of Use
© 2020 BeyondSpring Inc. All rights reserved.